BioCentury
ARTICLE | Clinical News

PRTX-100: Phase Ib started

January 18, 2016 8:00 AM UTC

Protalex began the open-label, dose-escalation, French Phase Ib PRTX-100-203 trial to evaluate 4 weekly doses of IV PRTX-100 in up to 30 adults with persistent/chronic ITP. ...